ATE231160T1 - Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel - Google Patents

Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel

Info

Publication number
ATE231160T1
ATE231160T1 AT00400286T AT00400286T ATE231160T1 AT E231160 T1 ATE231160 T1 AT E231160T1 AT 00400286 T AT00400286 T AT 00400286T AT 00400286 T AT00400286 T AT 00400286T AT E231160 T1 ATE231160 T1 AT E231160T1
Authority
AT
Austria
Prior art keywords
erythromycin derivatives
production
medicinal products
halo
formula
Prior art date
Application number
AT00400286T
Other languages
English (en)
Inventor
Alexis Denis
Claude Fromentin
Bertrand Heckmann
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE231160T1 publication Critical patent/ATE231160T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
AT00400286T 1999-02-04 2000-02-03 Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel ATE231160T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9901292A FR2789392B1 (fr) 1999-02-04 1999-02-04 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
ATE231160T1 true ATE231160T1 (de) 2003-02-15

Family

ID=9541593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00400286T ATE231160T1 (de) 1999-02-04 2000-02-03 Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel

Country Status (8)

Country Link
US (1) US6313101B1 (de)
EP (1) EP1026170B1 (de)
JP (2) JP5019665B2 (de)
AT (1) ATE231160T1 (de)
DE (1) DE60001182T2 (de)
DK (1) DK1026170T3 (de)
ES (1) ES2186615T3 (de)
FR (1) FR2789392B1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1137654A1 (de) * 1998-12-10 2001-10-04 Pfizer Products Inc. Carbamat- und carbazat-ketolide antibiotika
SK10172001A3 (sk) * 1999-01-27 2002-06-04 Pfizer Products Inc. Ketolidové antibiotiká
HUP0201516A3 (en) * 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
DE19948417A1 (de) * 1999-10-07 2001-04-19 Morphochem Ag Imidazol-Derivate und ihre Verwendung als Arzneimittel
DK1167376T3 (da) 2000-06-30 2004-10-25 Pfizer Prod Inc Makrolidantibiotika
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
US20090170790A1 (en) * 2004-10-25 2009-07-02 Biswajit Das Ketolide derivatives as antibacterial agents
CN105732745A (zh) 2007-10-25 2016-07-06 森普拉制药公司 大环内酯类抗菌剂的制备方法
EP2365747B1 (de) 2008-10-24 2018-04-11 Cempra Pharmaceuticals, Inc. Verfahren zur behandlung von magen-darm-erkrankungen
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (de) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Verfahren zur behandlung von malaria, tuberkulose und mac-erkrankungen
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN104860943B (zh) * 2015-05-18 2017-11-17 上海毕路得医药科技有限公司 5,7‑二氯‑1h‑咪唑并[4,5‑b]吡啶的合成方法
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DE60001182D1 (de) 2003-02-20
JP2011136990A (ja) 2011-07-14
EP1026170A1 (de) 2000-08-09
ES2186615T3 (es) 2003-05-16
FR2789392B1 (fr) 2001-10-05
DE60001182T2 (de) 2003-10-09
JP5222348B2 (ja) 2013-06-26
FR2789392A1 (fr) 2000-08-11
US6313101B1 (en) 2001-11-06
JP2000229993A (ja) 2000-08-22
DK1026170T3 (da) 2003-05-05
EP1026170B1 (de) 2003-01-15
JP5019665B2 (ja) 2012-09-05

Similar Documents

Publication Publication Date Title
ATE231160T1 (de) Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel
WO1999064409A3 (de) Benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
LU91761I2 (fr) Vernakalant et ses dérivés pharmaceutiquement acceptables et en particulier son sel d'hydrochlorure (BRINAVESS®)
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69332259D1 (de) Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung
IL123776A0 (en) Novel derivatives of cyclodepsipeptide PF 1022
PT992509E (pt) Novos derivados macrolidos
ATE159728T1 (de) Cis-epoxide derivate, verwendbar als irreversible hiv-protease inhibitoren und verfahren und zwischenprodukte zu ihrer herstellung
DE3673468D1 (de) N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid-salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
WO2001090102A3 (de) 6-heterocyclyl-3-oxo-3,4-dihydro-chinoxaline
DE60104986D1 (de) Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis
ATE123034T1 (de) Cephalosporinzwischenverbindungen, verfahren zu ihrer herstellung sowie zur herstellung ihrer endprodukte.
DE69906243D1 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
FR2787109B1 (fr) Nouveaux derives de 1,2-dithiolane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE60013515D1 (de) 4-Arylpiperidinderivate zur Behandlung von Pruritus
DK305184A (da) Hexahydropyrrolo(2,1-a)isoquinolin-derivater
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
ATE279434T1 (de) Neue (3,4,7,8,9,10) hexahydro-6, 10-dioxo-6h- pyridazino /1, 2-a/ /1, 2/ diazepin-1-carbonsäure-derivate, verfahren zu deren herstellung und deren verwendung zur herstellung pharmazeutischer wirkstoffe
ATE171450T1 (de) Thiazolidin-2,4-dion-derivate, salze hiervon sowie verfahren zur herstellung
DE60102113D1 (de) Ammonium-3,5,6-trihydroxyhexansäure-Derivate und Methoden zu ihrer Herstellung
ATE243219T1 (de) 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin
DE50000575D1 (de) Verfahren zur Herstellung von Folsäure
DE60114170D1 (de) Verfahren zur herstellung von decahydro-2a,4a,6a,8a-tetraazacyclopent[fg]acenaphthylene und dessen funktionelle derivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1026170

Country of ref document: EP

REN Ceased due to non-payment of the annual fee